Capravirine

S2Media&trade Viral Transport Medium (VTM) is recommended for the collection and transport of clinical specimens for the recovery of viral agents including, but not limited to, COVID-19, Herpes Simplex Type I, Herpes Simplex Type II,

Immunogen Synthetic peptide containing a sequence corresponding to a region within amino acids 2 and 13 of Capsid Protein (Dengue virus 2 ) according to NP_739591 Application Suggested starting dilutions are as follows: FACS: Assay-dependent

General description Purified inactivated capsid protein from CHIKV Mauritius strain (CHIKVMAU), challenged with live virus (CHIKVTHAI), followed by a final boost with inactivated antigen (CHIKVTHAI). Application Immunohistochemistry Analysis: A

General description Purified inactivated capsid protein from CHIKV Mauritius strain (CHIKVMAU), challenged with live virus (CHIKVTHAI), followed by a final boost with inactivated antigen (CHIKVTHAI). Application Immunohistochemistry Analysis: A

Beclabuvir is an allosteric inhibitor that binds to thumb site 1 of the hepatitis C virus ( HCV ) NS5B RNA-dependent RNA polymerase, and inhibits recombinant NS5B proteins from HCV genotypes 1, 3, 4, and 5 with IC 50 of &lt: 28 nM.In VitroBeclabuvir

Biochem/physiol Actions Bevirimat is the first in class HIV maturation inhibitor. It acts by inhibiting the processing of the Gag capsid (CA)/spacer peptide 1 (SP1), which causes accumulation of CA/SP1 (p25) precursor proteins and blocks

Biochem/physiol Actions Bevirimat is the first in class HIV maturation inhibitor. It acts by inhibiting the processing of the Gag capsid (CA)/spacer peptide 1 (SP1), which causes accumulation of CA/SP1 (p25) precursor proteins and blocks

Biochem/physiol Actions Filibuvir is an orally available, potent and selective inhibitor of the hepatitis C virus (HCV) nonstructural 5B (NS5B) RNA-dependent RNA polymerase that exhibits potent antiviral activity against subgenomic HCV replicons

Biochem/physiol Actions Filibuvir is an orally available, potent and selective inhibitor of the hepatitis C virus (HCV) nonstructural 5B (NS5B) RNA-dependent RNA polymerase that exhibits potent antiviral activity against subgenomic HCV replicons

InformationGlecaprevir Glecaprevir is a hepatitis C virus (HCV) nonstructural (NS) protein 3/4A protease inhibitor that targets the the viral RNA replication. It displays IC50 values ranging from 3.5 to 11.3 nM for clinical isolates of HCV genotypes

InformationGlecaprevir Glecaprevir is a hepatitis C virus (HCV) nonstructural (NS) protein 3/4A protease inhibitor that targets the the viral RNA replication. It displays IC50 values ranging from 3.5 to 11.3 nM for clinical isolates of HCV genotypes

InformationGlecaprevir Glecaprevir is a hepatitis C virus (HCV) nonstructural (NS) protein 3/4A protease inhibitor that targets the the viral RNA replication. It displays IC50 values ranging from 3.5 to 11.3 nM for clinical isolates of HCV genotypes